Publications by authors named "Joseph J Dajcs"

Claim this Profile
S
Staphylococcus petrasii sp. nov. including S. petrasii subsp. petrasii subsp. nov. and S. petrasii subsp. croceilyticus subsp. nov., isolated from human clinical specimens and human ear infections.
Roman Pantůček, Pavel Švec, Joseph J Dajcs, Ivana Machová, Jitka Černohlávková

Syst Appl Microbiol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.
Charles L Balzli, John Bartell, Joseph J Dajcs, Clare C McCormick, Armando R Caballero

Invest Ophthalmol Vis Sci· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin.
Rudolph S Wagner, David B Granet, Steven J Lichtenstein, Tiffany Jamison, Joseph J Dajcs

Clin Ophthalmol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
Peter A D'Arienzo, Rudolph S Wagner, Tiffany Jamison, Belinda Bell, Joseph J Dajcs

Adv Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas otitidis sp. nov., isolated from patients with otic infections.
Linda L Clark, Joseph J Dajcs, Celeste H McLean, John G Bartell, David W Stroman

Int J Syst Evol Microbiol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
Clare C McCormick, Joseph J Dajcs, Julian M Reed, Mary E Marquart, Richard J O'Callaghan

Curr Eye Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
David W Stroman, Joseph J Dajcs, Gale A Cupp, Barry A Schlech

Surv Ophthalmol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
Brett A Thibodeaux, Armando R Caballero, Joseph J Dajcs, Mary E Marquart, Lee S Engel

Ocul Immunol Inflamm· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis of Staphylococcus in the rabbit anterior chamber.
Dalia O Girgis, Julian M Reed, Kathryn S Monds, Joseph J Dajcs, Mary E Marquart

Invest Ophthalmol Vis Sci· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.
Mary E Marquart, Joseph J Dajcs, Armando R Caballero, Brett A Thibodeaux, Richard J O'Callaghan

Med Microbiol Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Joseph J Dajcs, Brett A Thibodeaux, Mary E Marquart, Dalia O Girgis, Mullika Traidej

Antimicrob Agents Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Brett A Thibodeaux, Joseph J Dajcs, Armando R Caballero, Mary E Marquart, Dalia O Girgis

Curr Eye Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host defense against bacterial keratitis.
Richard J O'Callaghan, Dalia O Girgis, Joseph J Dajcs, Gregory D Sloop

Ocul Immunol Inflamm· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes.
Dalia O Girgis, Joseph J Dajcs, Richard J O'Callaghan

Invest Ophthalmol Vis Sci· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit.
Joseph J Dajcs, Brett A Thibodeaux, Dalia O Girgis, Megan D Shaffer, Stephen M Delvisco

Invest Ophthalmol Vis Sci· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.
Judy M Moreau, Lisa L Conerly, Emma B H Hume, Joseph J Dajcs, Dalia O Girgis

Cornea· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
Joseph J Dajcs, Brett A Thibodeaux, Dalia O Girgis, Richard J O'Callaghan

DNA Cell Biol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corneal pathogenesis of Staphylococcus aureus strain Newman.
Joseph J Dajcs, Megan S Austin, Gregory D Sloop, Judy M Moreau, Emma B H Hume

Invest Ophthalmol Vis Sci· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis